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Abstract
Background: Bioactive compounds in wild medicinal mushrooms are known to contain potent antimicrobial
property. Hence, there is need to assess the antimicrobial properties of these wild mushrooms in order to
adequately utilize the bioactive compounds for the production of new antimicrobials and to curb the menace of
antibiotic resistance. In this study, the phytochemical property and antistaphylococcal activity of a wild medicinal
macrofungus, Lenzites quercina was assessed.
Methods: Staphylococcus species were isolated from clinical samples from two well patronized hospitals in Akure,
Ondo State, Nigeria. The isolates were identified based on standard microbiological methods. The sensitivity pattern of
the Staphylococcus species against some antibiotics was assessed. The inhibitory potential of ethanolic extract of
Lenzites quercina on the growth of the clinical Staphylococcal strains was carried out using agar well diffusion method.
Results: The percentage resistance displayed by forty two (42) Staphylococcus species against commonly used
antibiotics ranged from 25.0 to 100. Qualitative screening and quantity of some phytochemicals in Lenzites quercina
extract are revealed as follows: flavonoids (18.6 mg/g), saponins (2.8 mg/g), tannins (11.3 mg/g), tepernoids (1.16 mg/g)
and cardiac glycosides (0.84 mg/g). Inhibitory zones displayed by extract of Lenzites quercina against Staphylococcus
spp ranged from 6.0 mm to 22.0 mm at 50 mg/ml. The minimum inhibitory concentration (MIC) however varies from
6.25 mg/ml to ≥50 mg/ml. Extract of Lenzites quercina as well as commercial antibiotics (positive control) exhibited
potent antibacterial activity against Staphylococcus spp.
Conclusion: The phytochemicals in Lenzites quercina are responsible for the anti-staphylococci activity observed. These
phytochemicals can be further isolated and exploited to solve the recurrent problem of antibiotic resistance peculiar to
some species of Staphylococcus.
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Background
Staphylococcus species is a ubiquitous human pathogen;
microbiota of the skin and mucous membranes of the
humans, which have the ability to colonize and infect
both hospitalized and healthy people with life threaten-
ing infection [1]. S. saprophyticus, S. epidermidis and S.
aureus are responsible for wide range of infections such
as skin, soft tissue infections, bacteremia, infections of
the central nervous system, bone and joints skeletal
muscles, respiratory and urinary tracts, and infections
associated with intravascular devices; cystitis, renal, ur-
eteral stones and Urinary tract infection [2, 3].
Staphylococci had been recognized as major microor-
ganisms involve in nosocomial infection due to continu-
ous cross-resistance to beta-lactam and other antibiotics
like streptomycin, tetracycline, chloramphenicol, vanco-
mycin and erythromycin [4, 5]. Multidrug resistance is
now common among the pathogenic Staphylococci and
perhaps, greatest concern because of their intrinsic
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virulence, ability to cause a diverse array of life threatening
infections and capacity to adapt to different environmental
conditions [6].
The production of conventional antibiotics has increased
to achieve victory over the multidrug resistance of
Staphylococcus aureus and Staphylococcus epidermidis but
intake of inappropriate doses and incomplete dose by pa-
tients has negated the effort. This had contributed to less
effective bactericidal action of antibiotics and resulted to re-
sistant patterns observed in some pathogenic microorgan-
isms [7]. The overall reports on the emergence of antibiotic
resistance of Staphylococcus species had underscored the
action of new antibiotics products. Hence, phytomedicine
from wild macrofungi will be a great option toward treat-
ment of infection caused by these pathogenic organisms.
Wild macrofungi have been reported as natural source
of antimicrobials [8]. Therefore, the exploitation of nat-
ural products from wild macrofungi will be a useful
approach to reduce the increasing trend of multiple anti-
biotic resistance (MAR). Bioactive compounds such as
phenolics, polysaccharides, lectins, lentinan, active hexose
correlated compound (AHCC) in wild medicinal mush-
rooms are needed to be extracted and assessed for anti-
microbial effect against resistance pathogens. Lenzites
quercina is one of the widely available macrofungi with ac-
cumulated bioactive compounds that need to be screened
for antibacterial activity. This study therefore provides in-
formation on phytochemical constituents and antista-
phylococcal property of ethanolic extract of Lenzites
quercina against some resistance and pathogenic
Staphylococcus isolated from clinical samples.
Methods
Source of Staphylococcus species
Staphylococcus species used in this study were isolated
from clinical samples such as urine, stool, sputum, wound
swab and pus from Medical Microbiology Laboratory of
State Specialist Hospital and Don Bosco Hospital, Akure,
Nigeria. The methicillin resistant Staphylococcus aureus
(MRSA) and S. aureus (ATCC 29213) were used as con-
trol during the experiment. The control isolates were
soured from Medical Microbiology Department, Univer-
sity College Hospital (UCH), Ibadan, Oyo State, Nigeria.
Isolation and identification of Staphylococcus species
The culture media; mannitol salt agar (MSA, Oxoid) and
cystine lactose electrolyte deficient (CLED, Oxoid) were
prepared according to manufacturer’s instruction. The
clinical samples were plated on solidify media and incu-
bated at 36 °C for 24–48 hours. Colony of Staphylococ-
cus spp were sub cultured by streak method on nutrient
agar (NA, Lab M) and pure colony obtained were main-
tained on agar slants at 4 °C. A loopful of 18 h broth
containing organism was transferred to a clean glass
slide, Gram stained and examined under microscope.
Biochemical tests such as catalase, coagulase, urease, cit-
rate utilization, sugar fermentation and action of isolates
against novobiocin (5 μg) were carried out using the
methods of [9] and [10]. The results of biochemical test
were interpreted to confirm the identity of organisms
according to [10, 11].
Antibiotic sensitivity test
Antibiotic sensitivity pattern of isolated Staphylococcus spe-
cies was determined by using agar disc diffusion method
following the recommendation of the Clinical and Labora-
tory Standards Institute [12]. The inoculum was prepared
from 18 h broth culture of each isolate and adjusted to a
turbidity equivalent of 0.5 McFarland Standard. Inoculum
size (0.1 ml) was spread on Mueller- Hinton agar and the
antibiotic discs were placed at the equidistance of the
plate. The antibiotics used include; erythromycin (ERY 15
μg), cotrimoxazole (COT 25 μg), chloramphenicol (CHL
30 μg), novobiocin (NOV 5 μg), gentamicin (GEN 10 μg),
streptomycin (STR 30 μg), augmentin (AUG 30 μg) and
ciprofloxacin (CPR 5 μg). The zones of inhibition were
measured in millimeters and compared against standard
given by [12] to determine resistance and susceptibility.
Mushroom collection and preparation of extract
Lenzites quercina was collected from Aba Oyo farmland,
which is 1.5 km to Oba-nla, the Federal University of
Technology, Akure (Lat 07° 14IN Long 05° 11IE). Sample
of Lenzites quercina was collected in October, 2014. The
fruiting body was morphologically identified and con-
firmed by molecular tools using the internal transcribed
spacer (ITS) region of the rDNA. Voucher specimen was
deposited in the Department of Microbiology, Federal
University of Technology, Akure (FUTA). Sample of
Lenzites quercina was dried and ground to powder with
a mill machine (Retsch GmbH 5657 HAAN). Milled
sample (50 g) was soaked in 1000 ml of ethanol (95 % v/v)
for 72 h. The filtrate obtained through What man No.1
filter paper was concentrated using rotary evaporator (RE-
52A, UNION Laboratories, England) and dried extract
was kept at 4 °C for further used.
Phytochemical screening of the extract
The presence of phytochemicals such as flavonoids, alka-
loids, tannins, saponins, tepernoids, anthraquinones, ste-
roids, cardiac glycosides, and phlobatannins were assessed
using the methods described by [13, 14]. The methods are
briefly described as follows:
Test for flavonoids
Extract of 0.5 g was gently warm with distilled water
(2 ml) and then filtered. The filtrate was filled up to
2 ml and few drops of 10 % ferric chloride solution were
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added. A green-blue or violet colouration indicated the
presence of a phenolic hydroxyl group.
Test for alkaloids
Extract (0.5 g) was stirred with 5 ml of 1 % v/v aqueous
hydrochloric acid (HCl) for two minutes on a steam
water bath. The extract was filtered and few drops of
Dragendorff ’s reagent were added. A prominent yellow
to orange colour indicate that alkaloid was present.
Test for tannins
Ethanolic extract of Lenzites quercina (0.5 g) was mixed
with 2 ml of solution 2 % of FeCl3. A blue-green or black
coloration indicated the presence of phenols and tannins.
Test for saponins
This was carried out by putting the extract (1 g) in a test
tube and shaken very well. After, it was heated in a water
bath and observed for the formation of stable foam,
which was taken as an indication for the presence of
saponins.
Test for terpenoids (Salkowski’s Test)
Aliquot of extract (5 ml) was mixed with 2 mL of
chloroform. Then 2 mL of concentrated sulfuric acid
(H2SO4) was added carefully and shaken gently. A red-
dish brown coloration of the interphase was formed to
show positive results for the presence of terpenoids.
Test for anthraquinones
Borntrager’s test was used for the detection of anthra-
quinone. The extract (0.5 g) was shaken into 10 ml of
benzene, filtered and 5 ml of 10 % ammonia solution
added to the filtrate. The mixture was shaken and ob-
served for the presences of pink red or violet color in
the ammonia layer which indicates the presence of free
anthraquinones.
Test for steroids
Acetic anhydride (2 ml) was added to 0.5 g of the extract
and filtered. Sulphuric acid (2 ml) was added to the fil-
trate and observed for color change from violet to blue -
green, which indicates the presence of steroid.
Test for Phlobatannins
The mushroom extracts (0.2 g) were dissolved in 10 ml
of distilled water each and filtered. The filtrates were.
Test for cardiac glycosides
Extract was mixed with 2 ml of glacial acetic acid con-
taining 2 drops of 2 % FeCl3. The mixture was poured
into another tube containing 2 ml of concentrated sul-
furic acid. A brown ring at the interphase indicates the
presence of glycosides. The quantity of the screened
phytochemicals was determined using the standard methods
outlined by [13–15].
Antimicrobial activity of Lenzites quercina extract
Antimicrobial activity of extract was determined by agar
well diffusion method [16]. Staphylococcus species from
stock culture were cultivated on nutrient broth at 32 °C
for 18 h. The inoculum size was adjusted by serial dilu-
tion to obtained 0.5 McFarland turbidity standards. The
extract was reconstituted in 20 % v/v of dimethyl sulfox-
ide (DMSO). An aliquot of 0.1 ml containing organism
was aseptically transferred and evenly spread onto the
dried surface of sterile Mueller Hinton agar plate. A well
of 6 mm were bored in the agar plate with sterile cork
borer. The extract was sterilized through membrane fil-
ter (0.22 μm) and 0.1 ml was aseptically introduced into
the well in the Petri dishes already inoculated with
Staphylococcus spp. A volume of 0.1 ml of erythromycin
and metronidazole were used as positive control while
20 % of DMSO as negative control. The plates were in-
cubated at 36 °C for 24 h. The diameter of the inhibition
zones were measured in millimeters. The negative control
shows no zone of inhibition against tested organisms.
Determination of minimum inhibitory concentration of
the extract
Agar well diffusion method of [16] was used to screen the
antimicrobial effect of the extracts at different concentra-
tions. The minimum inhibitory concentration (MIC) was
carried out on the extract that had antimicrobial effect on
the isolated organisms. The concentrations of the extract
ranged from 6.25 mg/ml to 50 mg/ml. The test was car-
ried out in replicates (n = 3). The MIC was obtained by
taking the least concentration of the extract that shows in-
hibitory effect on the tested organisms.
Statistical analysis
Experiments were carried out in replicates and data ob-
tained were analyzed by one way analysis of variance
(ANOVA) and means were compared by Duncan mul-
tiple range test (SPSS 17.0 version). Differences were
considered significant at P ≤ 0.05
Results
Table 1 shows the antibiotic resistance pattern of Staphy-
lococci isolated from clinical samples in two Hospitals. The
percentage of antibiotic resistance for the tested Staphylo-
coccus spp ranged from 25 to 100 %. The indicator
organisms were mostly resistance to chloramphenicol, aug-
mentin, gentamicin, augmentin and erythromycin. It was
observed that Staphylococcus isolates were resistance to at
least one of the antibiotics used and no isolates were sus-
ceptible to all the tested antibiotics. The result of the phyto-
chemical contents of Lenzites quercina extract (Table 2)
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revealed the presence of flavonoids, saponins, alkaloids, tan-
nins, tepernoids and cardiac glycosides. Flavonoids have the
highest value of 18.6 mg/g while tannins, saponins and
tepernoids were 11.3 mg/g, 2.8 mg/g and 1.16 mg/g re-
spectively. Low quantity of alkaloids (0.48 mg/g) and car-
diac glycosides (0.84 mg/g) was observed in the ethanolic
extract of Lenzites quercina.
Table 3 shows the antistaphylococcal activity of ethanolic
extract of Lenzites quercina at 50 mg/ml. Ethanolic extract
of Lenzites quercina exhibited inhibitory action on the
tested isolates of S. aureus, S. epidermidis and S. saprophyti-
cus collected from well patronized hospitals in Akure,
Nigeria. Highest zone of inhibition (22 mm) was observed
for S. epidermidis. The extract exhibited inhibition on the
twenty–seven (27) species of Staphylococcus at 50 mg/ml,
which is 64.3 % of the indicator organisms. The control iso-
lates; MRSA and S. aureus (ATCC 29213) were also suscep-
tible to the ethanol extract of L. quercina at 50 mg/ml.
Table 4 shows minimum inhibitory concentrations (MIC)
of the extract against tested isolates of Staphylococcus spp.
Some species of Staphylococcus (35.7 %) was not inhibited
by the ethanolic extract of L. quercina at 50 mg/ml; there-
fore the range of minimum inhibitory concentration (MIC)
of the extract against the isolates was from 6.25 mg/ml to ≥
50 mg/ml.
Discussion
Staphylococci had been recognized as one of the major
pathogens of hospital acquired infections due to their re-
sistance to commercial antibiotics. The isolated species
of Staphylococcus show resistance against some tested
antibiotics (Table 1). The multiple antibiotic resistances
posed by species of Staphylococcus against most of the
antibiotics had been attributed to the acquisition of
Table 1 Resistance percent (%) of isolated Staphylococcus species from different clinical samples against some antibiotics
Organisms/source Samples Number of
isolates
Antibiotics
ERY COT CHL NOV GEN STR AUG CPR
SASH Urine 3 66.7 0.0 100 0.0 33.3 33.3 66.7 0.0
SASH Sputum 2 100 0.0 100 0.0 50.0 0.0 100 0.0
SASH Pus 4 100 50.0 75.0 0.0 0.0 50.0 75.0 50.0
SASH Stool 1 0.0 100 100 0.0 100 0.0 100 0.0
SASH Wound swab 6 83.3 66.7 100 0.0 50.0 33.3 50.0 33.3
SESH Pus 3 66.7 33.3 66.7 0.0 66.7 0.0 33.3 0.0
SESH Wound swab 3 33.3 66.7 66.7 0.0 0.0 0.0 33.3 0.0
SSSH Urine 4 25.0 0.0 75.0 100 25 50.0 50.0 0.0
SADB Urine 3 100 66.7 100 0.0 66.7 33.3 0.0 33.3
SADB Sputum 2 100 50 100 0.0 100 100 100 0.0
SADB Pus 3 66.7 33.3 66.7 0.0 33.3 33.3 100 0.0
SADB Stool 1 0.0 100 100 0.0 100 0.0 100 0.0
SADB Wound swab 3 100 100 33.3 0.0 33.3 100 100 33.3
SEDB Pus 1 0.0 100 0.0 0.0 100 0.0 0.0 0.0
SEDB Wound swab 3 100 33.3 66.7 0.0 33.3 100. 33.3 33.3
aMRSA 1 0.0 100 100 0.0 100 100 100 0.0
aS. aureus (ATCC 29213) 1 0.0 100 100 0.0 100 100 100 100
Values are mean of replicates (n = 3), 0.0: isolate(s) are susceptible to the antibiotic, aisolates are used as the control antibiotic codes were defined under methods
SASH Staphylococcus aureus from State Specialist Hospital, Akure,
SESH Staphylococcus epidermidis from State Specialist Hospital, Akure,
SSSH Staphylococcus saprophyticus from State Specialist Hospital, Akure,
SADB Staphylococcus aureus from Don Bosco Hospital, Akure,
SEDB Staphylococcus epidermidis from Don Bosco Hospital, Akure
Table 2 Phytochemical constituents of ethanolic extract
obtained from Lenzites quercina
Phytochemicals Extract of Lenzites quercina Quantity of
phytochemicals (mg/g)
Flavonoids + 18.6 ± 0.02
Alkaloids + 0.48 ± 0.0
Anthraquinones - 0.0
Saponins + 2.8 ± 0.0
Steroids - 0.0
Tannins + 11.3 ± 0.01
Phlobatannins - 0.0
Tepernoids + 1.6 ± 0.0
Cardiac glycosides + 0.84 ± 0.02
Key: − = absent, + = present, values are mean ± standard deviation
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antibiotic resistance genes [17, 18]. This has been a con-
tentious issue over the last three decades and therefore re-
quires prompt solution. The attention of researchers has
been focused on alternative antimicrobial agents that are
cheaper, safer and more efficacious. Macrofungi harbour a
large number of biologically active molecules, which have
Table 3 Zones of inhibition (mm) of ethanolic extract of Lenzites







Urine SASH-1 8.0a ± 0.0 14.0b ± 0.0 9.3a ± 0.1
Urine SASH-2 12.0b ± 0.0 10.0a ± 0.0 10.0a ± 0.1
Urine SASH-3 0.0a 15.0c ± 0.0 11.0b ± 0.0
Sputum SASH-4 0.0a 10.0b ± 0.0 0.0a
Sputum SASH-5 0.0a 8.3b ± 0.1 0.0a
Pus SASH-6 13.0a ±0.0 14.0a ± .0 24.0b ± 0.2
Pus SASH-7 15.0b ± 0.0 13.0a ±0.1 18.0c ± 0.0
Pus SASH-8 11.0a ±0.1 10.0a ±0.1 13.0b ± 0.0
Pus SASH-9 14.0a ±0.0 20.0c ± 0.0 17.0b ± 0.0
Stool SASH-10 0.0a 18.0c ± 0.0 14.2b ± 0.1
Wound swab SASH-11 10.0b ± 0.0 8.0a ± 0.1 17.1c ± 0.2
Wound swab SASH-12 18.0c ± 0.0 0.0a 15.2b ± 0.0
Wound swab SASH-13 11.0a ±0.3 17.0b ± 0.0 17.0b ± 0.6
Wound swab SASH-14 20.0c ± 0.0 0.0a 9.0b ± 0.0
Wound swab SASH-15 0.0a 0.0a 18.0b ± 0.0
Wound swab SASH-16 14.0b ± 0.2 21.0c ± 0.1 0.0a
Urine SADB-17 7.0b ± 0.02 10.0c ± 0.1 0.0a
Urine SABD-18 10.0b ± 0.0 0.0a 15.0c ± 0.0
Urine SADB-19 7.0a ±0.0 12.0b ± 0.0 23.0c ± 0.0
Sputum SADB-20 0.0a 10.3 ± 0.13 0.0a
Sputum SADB-21 0.0a 12.0b ± 0.0 0.0a
Pus SADB-22 17.0c ± 0.0 10.0b ± 0.0 0.0a
Pus SADB-23 12.0a ±0.0 13.1a ±0.3 19.0c ± 0.0
Pus SADB-24 16.0a ± 0.0 22.0b ± 0.1 20.0c ± 0.1
Stool SABD-25 0.0a 15.1b ± 0.1 21.0c ± 0.1
Wound swab SADB-26 0.0a 0.0a 18.0b ± 0.0
Wound swab SADB-27 6.0a ±0.0 18.0c ± 0.0 16.1b ± 0.3
Wound swab SADB-28 0.0a 15.0b ± 0.0 14.2b ± 0.1
Pus SEDB-29 8.0b ± 0.0 0.0a 20.0c ± 0.0
Wound swab SEDB-30 0.0a 0.0a 18.0b ± 0.0
Wound swab SEDB-31 13.0b ± 0.0 0.0a 16.0c ± 0.0
Wound swab SEDB-32 0.0a 17.0c ± 0.0 9.0b ± 0.0
Pus SESH-33 0.0a 0.0a 11.0b ± 0.0
Pus SESH-34 10.0b ± 0.0 8.0a ±0.0 13.0c ± 0.0
Pus SESH-35 22.0c ± 0.0 0.0a 10.3b ± 0.1
Wound swab SESH-36 18.0c ± 0.3 14.3b ± 0.2 0.0a
Wound swab SESH-37 14.0b ± 0.0 0.0a 15.0b ± 0.0
Wound swab SESH-38 0.0a 9.0b ± 0.0 0.0a
Urine SSSH-39 10.0b ± 0.0 11.0b ± 0.0 0.0a
Urine SSSH-40 16.1b ± 0.3 0.0a 16.0b ± 0.0
Urine SSSH-41 8.0b ± 0.0 9.0b ± 0.0 0.0a
Table 3 Zones of inhibition (mm) of ethanolic extract of Lenzites
quercina against tested species of Staphylococcus at 50 mg/ml
(Continued)
Urine SSSH-42 0.0a 11.0c ± 0.0 7.0b ± 0.0
*MRSA 13.3c ± 0.2 11.0b ± 0.0 8.3a ± 0.2
*S. aureus
(ATCC 29213)
14.3ab ± 0.1 15.0b ± 0.0 12.7a ± 0.8
Values are mean ± sd of replicates (n = 3), means with different letters within a
row are significantly different by Duncan (P < 0.05), 0.0 = no zone of inhibition
observed, *isolates are used as the control
SASH1-16 Staphylococcus aureus from State Specialist Hospital, Akure,
SADB17-28 Staphylococcus aureus from Don Bosco Hospital, Akure,
SEDB29-32 Staphylococcus epidermidis from Don Bosco Hospital, Akure,
SESH33-38 Staphylococcus epidermidis from State Specialist Hospital, Akure,
SSSH39-42 Staphylococcus saprophyticus from State Specialist Hospital, Akure
Table 4 Minimum Inhibitory Concentration (MIC) of Lenzites
quercina extract against tested organisms
Tested isolates MIC mg/ml Tested isolates MIC mg/ml
SASH-1 25.0 SADB-22 25.0
SASH-2 25.0 SADB-23 6.25
SASH-3 >50 SADB-24 6.25
SASH-4 >50 SABD-25 >50
SASH-5 >50 SADB-26 >50
SASH-6 50.0 SADB-27 12.5
SASH-7 12.5 SADB-28 >50
SASH-8 6.25 SEDB-29 12.5
SASH-9 50.0 SEDB-30 >50
SASH-10 >50 SEDB-31 12.5
SASH-11 6.25 SEDB-32 >50
SASH-12 12.5 SESH-33 >50
SASH-13 25.0 SESH-34 12.5
SASH-14 6.25 SESH-35 25.0
SASH-15 >50 SESH-36 6.25
SASH-16 25.0 SESH-37 12.5
SADB-17 12.5 SESH-38 >50
SABD-18 50.0 SSSH-39 12.5
SADB-19 25.0 SSSH-40 6.25
SADB-20 >50 SSSH-41 12.5
SADB-21 >50 SSSH-42 >50
aMRSA 50 aS. aureus (ATCC 29213) 12.5
Values are mean of replicates (n = 3), aisolates are used as the control
SASH 1–16 Staphylococcus aureus from State Specialist Hospital, Akure,
SADB 17–28 Staphylococcus aureus from Don Bosco Hospital, Akure,
SEDB 29–32 Staphylococcus epidermidis from Don Bosco Hospital, Akure,
SESH33-38 Staphylococcus epidermidis from State Specialist Hospital, Akure,
SSSH39-42 Staphylococcus saprophyticus from State Specialist Hospital, Akure
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tremendous therapeutic potentials in curing various
ailments; by enhancing the activity of different types of
immune cells, destroying both virus-infected and cancer-
ous cells [19]. The quality and quantity of phytochemical
obtained in ethanolic extract of Lenzites quercina (Table 3)
had been reported in other medicinal mushrooms. These
phytochemicals are responsible for antibacterial and anti-
fungal properties of the mushrooms [20] and [21]. Al-
though, the quantity of phytochemicals varies, which could
be influence by climate, season, location, substrate, solvent
or extraction methods adopted. The phytochemicals in
medicinal mushrooms may therefore be used as an alterna-
tive phytotherapeutic agent to promote human health.
Ethanolic extract of Lenzites quercina displayed inhibi-
tory effect against S. saprophyticus, S. epidermidis and S.
aureus isolated from clinical samples in two well patron-
ized hospitals in Akure, Nigeria. The zones of inhibition
obtained for the extract ranged from 6 mm to 22 mm
while commercial antibiotics have zone of inhibition of
8 mm to 24 mm. The finding of Ameri et al. [22] had
reported inhibitory zones (17–33) mm displayed by
sesquiterpene obtained from selected Ganoderma species
against different isolates of Methicillin resistant Staphy-
lococcus aureus (MRSA). Suay et al. [23] had earlier
screened some Spanish basidiomycetes for antimicrobial
agents and their result indicated that different taxonomic
group of fungi are of potential therapeutic interest. Simi-
larly, Mustafa and Fatma [24] detected 14 mushroom spe-
cies with significant antimicrobial activity against some
target microorganisms such as Staphylococcus aureus,
Enterococcus feacalis, Streptococcus spp and Salmonella
typhi. Ethanolic extract of Lenzites quercina and commer-
cial antibiotics widely exhibited inhibitory action (Table 2)
against the tested pathogenic organisms. This may be as a
result of Lenzites quercina extract showing varying degree
of affinity to different target sites within bacterial cells.
Cell wall of Gram positive bacteria is less complicated, it
freely allows hydrophobic molecules to flow in [25], there-
fore the presence of phenolic compounds and other phy-
tochemicals in the extract can easily penetrate the cell
wall, interfere with cytoplasm, inhibits the production of
enzymes and proteins synthesis. This present study thus
supports the claims of [26] and [27]. These researchers as-
sociated the antimicrobial, anticancer, anti-inflammatory,
antioxidant activities of wild macrofungi to diverse sec-
ondary metabolites. The metabolites are needed to be
identified and isolated for the development of prolific and
new pharmaceutical compounds.
Conclusions
The study revealed that ethanolic extract of Lenzites
quercina contains bioactive compounds that are effica-
cious against clinically isolated Staphylococcus aureus, a
notorious pathogenic agent that has developed resistance
against commonly used antibiotic agents. Hence, the
bioactive compounds from Lenzites quercina may be a
good alternative to commercially available antibiotics that
are becoming less effective on Staphylococcus aureus. The
isolation and identification of the specific compound re-
sponsible for the antistaphylococcus effect of Lenzites
quercina extract is therefore the next research focus.
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